29 Mar The Medicine Maker – Stem Cells: The Next (Re)generation
“Through its Phase I/IIb EXCELLENT clinical trial, CellProthera, a France-based biotechnology research company focusing on cardiac tissue regeneration, is demonstrating the safety and efficacy of a cell therapy approach to regenerating tissue following myocardial infarction. Here, CEO Matthieu de Kalbermatten shares his ambition to fulfil the promise of stem cell research”…
The Medicine Maker | Rob Coker | 03/29/2023